Samsara BioCapital, LLC Diversified Active

Location: Palo Alto, CA

CIK: 0001744967 · Show all filings

Period: Q2 2019 (← Previous) (Next →)

Filing Date: Aug 14, 2019

Total Value: $151M (100.0% shares, 0.0% debt)

Holdings (21)

— Intercept Pharmaceuticals Inc 17.4%

Value $26.31M Shares 330,697 Est. Cost $93.11 Unrealized —

— Odonate Therapeutics Inc 14.9%

Value $22.6M Shares 615,850 Est. Cost $14.81 Unrealized —

— Allakos Inc 12.5%

Value $18.88M Shares 446,905 Est. Cost $52.27 Unrealized —

— Syros Pharmaceuticals Inc 10.1%

Value $15.23M Shares 1,726,603 Est. Cost $6.82 Unrealized —

— Sutro BioPharma Inc 8.5%

Value $12.81M Shares 1,125,579 Est. Cost $9.02 Unrealized —

— Principia Biopharma Inc 8.4%

Value $12.73M Shares 383,480 Est. Cost $27.39 Unrealized —

— Atreca Inc 7.4%

Value $11.14M Shares 591,368 Est. Cost $18.84 Unrealized —

GOSS Gossamer Bio Inc 5.5%

Value $8.353M Shares 376,583 Est. Cost $20.85 Unrealized -8.3%

LQDA Liquidia Technologies Inc 3.5%

Value $5.268M Shares 658,532 Est. Cost $20.06 Unrealized -53.2%

— Hookipa Pharma Inc 2.4%

Value $3.569M Shares 530,245 Est. Cost $6.73 Unrealized —

— Aravive Inc 1.8%

Value $2.656M Shares 442,733 Est. Cost $3.52 Unrealized —

KALV KalVista Pharmaceuticals Inc 1.7%

Value $2.625M Shares 118,500 Est. Cost $20.10 Unrealized +16.7%

— Catabasis Pharmaceuticals Inc 1.6%

Value $2.421M Shares 300,000 Est. Cost $4.37 Unrealized —

— Evelo Biosciences Inc 1.3%

Value $2.043M Shares 227,529 Est. Cost $13.01 Unrealized —

— Sunesis Pharmaceuticals Inc 1.0%

Value $1.534M Shares 2,110,913 Est. Cost $1.21 Unrealized —

UROV Urovant Sciences Ltd 0.8%

Value $1.246M Shares 157,480 Est. Cost $6.59 Unrealized —

— Regulus Therapeutics Inc 0.7%

Value $1.131M Shares 904,407 Est. Cost $1.25 Unrealized —

— Millendo Therapeutics Inc 0.3%

Value $521K Shares 45,101 Est. Cost $7.96 Unrealized —

— Surface Oncology Inc 0.1%

Value $221K Shares 78,300 Est. Cost $4.24 Unrealized —

PDSB PDS Biotechnology Corp 0.0%

Value $55,000 Shares 9,166 Est. Cost $8.36 Unrealized -21.8%

— Trillium Therapeutics Inc 0.0%

Value $24,000 Shares 71,619 Est. Cost $1.70 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	Intercept Pharmaceuticals Inc	330,697	$26.31M	17.4%	$93.11	—	COM	45845P108
—	Odonate Therapeutics Inc	615,850	$22.6M	14.9%	$14.81	—	COM	676079106
—	Allakos Inc	446,905	$18.88M	12.5%	$52.27	—	COM	01671P100
—	Syros Pharmaceuticals Inc	1,726,603	$15.23M	10.1%	$6.82	—	COM	87184Q107
—	Sutro BioPharma Inc	1,125,579	$12.81M	8.5%	$9.02	—	COM	869367102
—	Principia Biopharma Inc	383,480	$12.73M	8.4%	$27.39	—	COM	74257L108
—	Atreca Inc	591,368	$11.14M	7.4%	$18.84	—	COM	04965G109
GOSS	Gossamer Bio Inc	376,583	$8.353M	5.5%	$20.85	-8.3%	COM	38341P102
LQDA	Liquidia Technologies Inc	658,532	$5.268M	3.5%	$20.06	-53.2%	COM	53635D202
—	Hookipa Pharma Inc	530,245	$3.569M	2.4%	$6.73	—	COM	43906K100
—	Aravive Inc	442,733	$2.656M	1.8%	$3.52	—	COM	03890D108
KALV	KalVista Pharmaceuticals Inc	118,500	$2.625M	1.7%	$20.10	+16.7%	COM	483497103
—	Catabasis Pharmaceuticals Inc	300,000	$2.421M	1.6%	$4.37	—	COM	14875P206
—	Evelo Biosciences Inc	227,529	$2.043M	1.3%	$13.01	—	COM	299734103
—	Sunesis Pharmaceuticals Inc	2,110,913	$1.534M	1.0%	$1.21	—	COM	867328700
UROV	Urovant Sciences Ltd	157,480	$1.246M	0.8%	$6.59	—	COM	G9381B108
—	Regulus Therapeutics Inc	904,407	$1.131M	0.7%	$1.25	—	COM	75915K200
—	Millendo Therapeutics Inc	45,101	$521K	0.3%	$7.96	—	COM	60040X103
—	Surface Oncology Inc	78,300	$221K	0.1%	$4.24	—	COM	86877M209
PDSB	PDS Biotechnology Corp	9,166	$55,000	0.0%	$8.36	-21.8%	COM	70465T107
—	Trillium Therapeutics Inc	71,619	$24,000	0.0%	$1.70	—	COM	89620X506